Gallagher Duncan
SEC CIK 1780880 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HCAT | Health Catalyst, Inc. | Dir | 132.0K | $175.0K | $62.6K | 14 | 2022-06-14 | 2026-02-17 |
Most active insiders at HCAT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Larson-Green Julie | Dir | — | $128.2K |
| 2 | Kohl Simeon | CEO, Dir | $105.4K | — |
| 3 | Landry Benjamin | GC | — | $72.4K |
| 4 | Albert Benjamin | Pres, COO | — | — |
| 5 | Hoggard Green Jill | Dir | — | — |
| 6 | Freeman Kevin Lee | Chief Commercial Off | — | — |
| 7 | Alger Jason | CFO | — | — |
| 8 | Burton Daniel D. | CEO, Dir | — | — |
| 9 | Gallagher Duncan | Dir | — | — |
| 10 | Llewelyn Linda | CHRO | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-17 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +7,562 | 132.0K | +6% | $0 | |
| 2025-12-03 | 2025-12-01 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +6,209 | 124.5K | +5% | $0 | |
| 2025-09-05 | 2025-09-01 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +4,970 | 118.3K | +4% | $0 | |
| 2025-07-10 | 2025-07-09 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +36.2K | 113.3K | +47% | $0 | |
| 2025-06-03 | 2025-06-01 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +4,080 | 77.1K | +6% | $0 | |
| 2025-03-04 | 2025-03-01 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +3,033 | 73.0K | +4% | $0 | |
| T | 2025-01-02 | 2024-12-30 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | S - Sale | $6.93 | -4,500 | 69.9K | -6% | -$31.2K |
| T | 2024-12-27 | 2024-12-23 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | S - Sale | $6.98 | -4,500 | 74.4K | -6% | -$31.4K |
| 2024-12-03 | 2024-12-01 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +2,001 | 78.9K | +3% | $0 | |
| 2024-09-10 | 2024-09-01 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +2,414 | 76.9K | +3% | $0 | |
| 2024-06-17 | 2024-06-13 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +20.8K | 74.5K | +39% | $0 | |
| M | 2023-06-16 | 2023-06-14 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +18.3K | 53.7K | +52% | $0 |
| M | 2022-08-19 | 2022-08-18+ | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | P - Purchase | $11.66 | +15.0K | 35.4K | +74% | +$175.0K |
| 2022-06-16 | 2022-06-14 | HCAT | Health Catalyst, Inc. | Gallagher Duncan | Dir | A - Grant | $0.00 | +11.7K | 20.4K | +134% | $0 |
Purchase Sale Sale after option exercise All abbreviations